ScholarIQanswers from OpenAlex

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis

PaperCitations, authors & open-access status

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis have?

ScholarIQcitation count

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis has 88 citations in the OpenAlex counts ScholarIQ stores.

When was Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis published?

ScholarIQyear

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis has 2019 year in the ScholarIQ index.

What is the open-access status of Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis?

ScholarIQoa status

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis has gold oa status in the ScholarIQ index.

What is the DOI of Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis?

ScholarIQdoi

The DOI for Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis is on the source record.

What is the PMID of Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis?

ScholarIQpmid

The PMID for Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis is on the source record.

What is the OpenAlex record for Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis?

ScholarIQopenalex

The OpenAlex for Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial